Navigation Links
Endocrinology Market to 2018 - Advanced Injection Devices for Growth Hormone and Somatostatin will Improve Ease of Use for Patients
Date:5/2/2012

NEW YORK, May 2, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

 

Endocrinology Market to 2018 - Advanced Injection Devices for Growth Hormone and Somatostatin will Improve Ease of Use for Patients

http://www.reportlinker.com/p0789008/Endocrinology-Market-to-2018---Advanced-Injection-Devices-for-Growth-Hormone-and-Somatostatin-will-Improve-Ease-of-Use-for-Patients.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Therapy

 

Endocrinology Market to 2018 - Advanced Injection Devices for Growth Hormone and Somatostatin will Improve Ease of Use for Patients

 

Summary

 

GBI Research, the leading business intelligence provider, has released its latest research "Endocrinology Market to 2018-Advanced Injection Devices for Growth Hormone and Somatostatin will Improve Ease of Use for Patients", which provides insights into the endocrine disease therapeutics market until 2018. The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research's team of industry experts. The report provides an in-depth analysis of the major endocrine markets including growth hormone deficiency market, acromegaly market, male Hypogonadism market and hypothyroidism market. The report also provides the share of generics in the global endocrinology as well as in each indication market. The report examines the global endocrine disorders treatment usage patterns. It provides the geographical distribution of growth hormone deficiency, acromegaly, male hypogonadism, hypothyroidism and markets across the US, the top five countries of Europe and Japan. The report also includes insights into the endocrinology Research and Development (R&D) product pipeline and explores the competitive landscape, including major players in the market. Finally, the report includes analysis on Mergers and Acquisitions (M&A) and licensing agreements that took place in the endocrinology market.

 

GBI Research's analysis shows that the overall global endocrinology market for the four indications was valued at $6.0 billion in 2010. It grew from $4.0 billion in 2004 at a CAGR of 6.9%. The market is expected to witness series of patent expiries , generic erosion and possible launches of novel molecules. The market is expected to witness comparatively moderate growth with a CAGR of 8.0% between 2010 and 2018, and is estimated to reach $11.2 billion in 2018. Patent expiries of blockbuster drugs such as Sandostatin LAR, Norditropin will restrict the growth of the market. The rapid uptake of novel dosage forms and formulations of existing drugs will increase the number of patients on treatment. Increased awareness among the general population about rare endocrine disorders will lead to an increase in market size in the forecast period.

 

Scope

 

- Data and analysis on the endocrinology market in the leading geographies of the world – the US, the UK, Germany, France, Italy, Spain, and Japan.

- Annualized market data for the endocrinology market from 2004 to 2010, with forecasts to 2018.

- Market data on the geographical landscape and therapeutic landscape, including market size, market share, annual cost of therapy, sales volume and treatment usage patterns such as disease population, treatment seeking population, diagnosis population and prescription population.

- Share of the generics in the global endocrinology market and for the market of each indication covered in the report.

- Key drivers and restraints that had a significant impact on the market.

- The competitive landscape of the global market including top companies benchmarking. The key companies studied in this report are Pfizer, Abbott, Novartis and Eli Lilly.

- Key M&A activities and licensing agreements that took place in 2009 and 2011 in the endocrinology market.

 

Reasons to buy

 

- Align your product portfolio to the markets with high growth potential.

- Build effective strategies to launch their pipeline products by identifying potential geographies with strong growth.

- Exploit in-licensing and out-licensing opportunities by identifying products that might fill portfolio gaps.

- Develop key strategic initiatives by studying the key strategies of top competitors.

- Create a more tailored country strategy through the understanding of key drivers and barriers and market potential of each indication.

- Develop market-entry and market expansion strategies by identifying the geographic markets poised for strong growth.

- Reinforce R&D pipelines by identifying new target mechanisms which can produce first-in-class molecules which are safer and more efficacious.

 

 

 

1 Table of Contents

1 Table of Contents 4

1.1 List of Tables 6

1.2 List of Figures 7

2 Endocrinology Market to 2018 - Introduction 9

2.1 GBI Research Report Guidance 10

3 Endocrinology Market to 2018 - Market Overview 11

3.1 Introduction 11

3.2 Revenue Forecasts for the Global Endocrinology Market 12

3.2.1 Revenue 12

3.2.2 Annual Cost of Therapy 13

3.2.3 Treatment Usage Patterns 14

3.3 Global Endocrinology Market Drivers 16

3.3.1 Rapid Uptake of New Formulation Products and Improved Injection Devices 16

3.3.2 Maintenance of Market Exclusivity and Revenues of Blockbuster Drugs by Extending Patent Life through Novel Drug Delivery Technologies 16

3.4 Global Endocrinology Market Restraints 17

3.4.1 Patent Expiries of Major Blockbuster Drugs Including Sandostatin LAR and Norditropin 17

3.4.2 Low Treatment Adherence in Growth Hormone Deficiency and Acromegaly Patients 17

3.5 Generics Share in the Global Endocrinology Market 18

4 Endocrinology Market to 2018 - Geographical Landscape 19

4.1 Revenue Analysis by Country 19

4.2 The US 21

4.2.1 Revenue 21

4.2.2 Annual Cost of Therapy 22

4.2.3 Treatment Usage Patterns 23

4.3 Top Five Countries in Europe 25

4.3.1 Revenue 25

4.3.2 Revenue Analysis by Country 26

4.3.3 Annual Cost of Therapy 27

4.3.4 Treatment Usage Patterns 28

4.4 Japan 30

4.4.1 Revenue 30

4.4.2 Annual Cost of Therapy 31

4.4.3 Treatment Usage Patterns 32

5 Endocrinology Market to 2018 - Therapeutic Landscape 34

5.1 Growth Hormone Deficiency 34

5.1.1 Introduction 34

5.1.2 Treatment Flow Algorithm for Growth Hormone Deficiency 35

5.1.3 Revenue 36

5.1.4 Revenue Analysis by Country 37

5.1.5 Annual Cost of Therapy 39

5.1.6 Treatment Usage Patterns 40

5.2 Acromegaly 42

5.2.1 Introduction 42

5.2.2 Treatment Flow Algorithm for Acromegaly 43

5.2.3 Revenue 44

5.2.4 Revenue Analysis by Country 45

5.2.5 Annual Cost of Therapy 47

5.2.6 Treatment Usage Patterns 48

5.3 Male Hypogonadism 49

5.3.1 Introduction 49

5.3.2 Treatment Flow Algorithm for Male Hypogonadism 50

5.3.3 Revenue 51

5.3.4 Revenue Analysis by Country 52

5.3.5 Annual Cost of Therapy 54

5.3.6 Treatment Usage Patterns 55

5.4 Hypothyroidism 57

5.4.1 Introduction 57

5.4.2 Treatment Flow Algorithm for Hypothyroidism 58

5.4.3 Revenue 59

5.4.4 Revenue Analysis by Country 61

5.4.5 Annual Cost of Therapy 63

5.4.6 Treatment Usage Patterns 64

6 Endocrinology Market to 2018 - Competitive Landscape 66

6.1 Market Share Analysis 66

6.2 Competitive Profiling 67

6.2.1 Pfizer 67

6.2.2 Novartis 69

6.2.3 Abbott 70

6.2.4 Novo Nordisk 71

6.2.5 Eli Lilly 72

7 Endocrinology Market to 2018 - Pipeline Analysis 73

7.1 Introduction 73

7.1.1 Research and Development Pipeline - Endocrinology Disorders Market 73

7.1.2 Most Promising Pipeline Molecules 77

8 Endocrinology Market to 2018 - Strategic Consolidations 79

8.1 Overview 79

8.2 Deals by Type 79

8.2.1 Pfizer Acquires King Pharmaceuticals in February 2011 79

8.2.2 Ipsen Acquires Tercica in October 2008 79

8.3 R&D Licensing Agreements 80

8.3.1 Deals by Indication 80

8.3.2 Deals by Phase 81

8.3.3 Deals by Geography 82

8.3.4 Licensing Agreements for Drugs in Phase II and Phase III 82

8.3.5 Licensing Agreements for Approved Drugs 84

9 Endocrinology Market to 2018 - Appendix 86

9.1 Market Definitions 86

9.2 Abbreviations 86

9.3 Research Methodology 87

9.3.1 Coverage 87

9.3.2 Secondary Research 87

9.3.3 Primary Research 88

9.4 Therapeutic Landscape 88

9.4.2 Market Size by Geography 90

9.5 Geographical Landscape 91

9.6 Pipeline Analysis 91

9.7 Competitive Landscape 91

9.7.1 Expert Panel Validation 91

9.8 Contact Us 91

9.9 Disclaimer 92

9.10 Sources 92

 

1.1 List of Tables

 

Table 1: Endocrinology Market, Global, Revenue, $bn, 2004-2010 12

Table 2: Endocrinology Market, Global, Revenue Forecasts, $bn, 2010-2018 12

Table 3: Endocrinology Market, Global, Annual Cost of Therapy, $, 2004-2010 13

Table 4: Endocrinology Market, Global, Annual Cost of Therapy, $, 2010-2018 13

Table 5: Endocrinology Market, Global, Treatment Usage Patterns, Millions, 2004-2010 14

Table 6: Endocrinology Market, Global, Treatment Usage Patterns, Thousands, 2010-2018 15

Table 7: Endocrinology Market, Global, Revenue by Country, $m, 2004-2010 19

Table 8: Endocrinology Market, Global, Revenue Forecasts by Country, $m, 2010-2018 20

Table 9: Endocrinology Market, The US, Revenue, $m, 2004-2010 21

Table 10: Endocrinology Market, The US, Revenue Forecasts, $m, 2010-2018 21

Table 11: Endocrinology Market, The US, Annual Cost of Therapy, $, 2004-2010 22

Table 12: Endocrinology Market, The US, Annual Cost of Therapy, $, 2010-2018 22

Table 13: Endocrinology Market, The US, Treatment Usage Patterns, Millions, 2004-2010 23

Table 14: Endocrinology Market, The US, Treatment Usage Patterns, Millions, 2010-2018 23

Table 15: Endocrinology Market, Top Five Countries of Europe, Revenue, $m, 2004-2010 25

Table 16: Endocrinology Market, Top Five Countries of Europe, Revenue Forecasts, $m, 2010-2018 25

Table 17: Endocrinology Market, Top Five Countries of Europe, Revenue by Country, $m, 2004-2010 26

Table 18: Endocrinology Market, Top Five Countries of Europe, Revenue Forecasts by Country, $m, 2010-2018 26

Table 19: Endocrinology Market, Top Five Countries of Europe, Annual Cost of Therapy, $, 2004-2010 27

Table 20: Endocrinology Market, Top Five Countries of Europe, Annual Cost of Therapy, $, 2010-2018 28

Table 21: Endocrinology Market, Top Five Countries of Europe, Treatment Usage Patterns, Millions, 2004-2010 29

Table 22: Endocrinology Market, Top Five Countries of Europe, Treatment Usage Patterns, Millions, 2010-2018 29

Table 23: Endocrinology Market, Japan, Revenue, $m, 2004-2010 30

Table 24: Endocrinology Market, Japan, Revenue Forecasts, $m, 2010-2018 30

Table 25: Endocrinology Market, Japan, Annual Cost of Therapy, $, 2004-2010 31

Table 26: Endocrinology Market, Japan, Annual Cost of Therapy, $, 2010-2018 31

Table 27: Endocrinology Market, Japan, Treatment Usage Patterns, Millions, 2004-2010 32

Table 28: Endocrinology Market, Japan, Treatment Usage Patterns, Millions, 2010-2018 33

Table 29: Growth Hormone Deficiency Therapeutics Market, Global, Revenue, $bn, 2004-2010 36

Table 30: Growth Hormone Deficiency Therapeutics Market, Global, Revenue Forecasts ($bn), 2010-2018 36

Table 31: Growth Hormone Deficiency Therapeutics Market, Global, Revenue by Country, $m, 2004-2010 37

Table 32: Growth Hormone Deficiency Therapeutics Market, Global, Revenue by Country, $m, 2010-2018 38

Table 33: Growth Hormone Deficiency Therapeutics Market, Global, Annual Cost of Therapy, $, 2004-2010 39

Table 34: Growth Hormone Deficiency Therapeutics Market, Global, Annual Cost of Therapy, $, 2010-2018 39

Table 35: Endocrinology Market, Growth Hormone Deficiency Therapeutics Market, Global, Treatment Usage Patterns, Thousands, 2004-2010 40

Table 36: Growth Hormone Deficiency Therapeutics Market, Global, Treatment Usage Patterns, Thousands, 2010-2018 41

Table 37: Acromegaly Therapeutics Market, Global, Revenue, $m, 2004-2010 44

Table 38: Acromegaly Therapeutics Market, Global, Revenue Forecasts, $m, 2010-2018 44

Table 39: Acromegaly Therapeutics Market, Global, Revenue by Country, $m, 2004-2010 45

Table 40: Acromegaly Therapeutics Market, Global, Revenue Forecasts by Country, $m, 2010-2018 46

Table 41: Acromegaly Therapeutics Market, Global, Annual Cost of Therapy, $, 2004-2010 47

Table 42: Acromegaly Therapeutics Market, Global, Annual Cost of Therapy, $, 2010-2018 47

Table 43: Acromegaly Therapeutics Market, Global, Treatment Usage Patterns, Thousand, 2004-2010 48

Table 44: Acromegaly Therapeutics Market, Global, Treatment Usage Patterns, Thousand, 2010-2018 48

Table 45: Male Hypogonadism Therapeutics Market, Global, Revenue, $m, 2004-2010 51

Table 46: Male Hypogonadism Therapeutics Market, Global, Revenue Forecasts, $m, 2010-2018 51

Table 47: Male Hypogonadism Therapeutics Market, Global, Revenue by Country, $m, 2004-2010 52

Table 48: Male Hypogonadism Therapeutics Market, Global, Revenue by Country, $m, 2010-2018 53

Table 49: Male Hypogonadism Therapeutics Market, Global, Annual Cost of Therapy, $, 2004-2010 54

Table 50: Male Hypogonadism Therapeutics Market, Global, Annual Cost of Therapy, $, 2010-2018 54

Table 51: Male Hypogonadism Therapeutics Market, Global, Treatment Usage Patterns, Millions, 2004-2010 55

Table 52: Male Hypogonadism Therapeutics Market, Global, Treatment Usage Patterns, Millions, 2010-2018 56

Table 53: Hypothyroidism Therapeutics Market, Global, Revenue, $m, 2004-2010 59

Table 54: Hypothyroidism Therapeutics Market, Global, Revenue Forecasts, $m, 2010-2018 59

Table 55: Hypothyroidism Therapeutics Market, Global, Revenue by Country, $m, 2004-2010 61

Table 56: Hypothyroidism Therapeutics Market, Global, Revenue by Country, $m, 2010-2018 62

Table 57: Hypothyroidism Therapeutics Market, Global, Annual Cost of Therapy, $, 2004-2010 63

Table 58: Hypothyroidism Therapeutics Market, Global, Annual Cost of Therapy , $, 2010-2018 63

Table 59: Hypothyroidism Therapeutics Market, Global, Treatment Usage Patterns, Millions, 2004-2010 64

Table 60: Hypothyroidism Therapeutics Market, Global, Treatment Usage Patterns, Millions, 2010-2018 65

Table 61: Endocrinology Market, Global, R&D Pipeline by Phase and by Indication, 2011 75

Table 62: Endocrinology Market, Global, Licensing Agreements for Drugs in Phase II and Phase III, 2005-2011 82

Table 63: Endocrinology Market, Global, Licensing Agreements for Approved Drugs, 2005-2011 84

 

1.2 List of Figures

 

Figure 1: Endocrinology Market, Global, Drivers and Restraints, 2011 11

Figure 2: Endocrinology Market, Global, Revenue Forecasts, $bn, 2004-2018 12

Figure 3: Endocrinology Market, Global, Annual Cost of Therapy, $, 2004-2018 13

Figure 4: Endocrinology Market, Global, Treatment Usage Patterns, Millions, 2004-2018 14

Figure 5: Endocrinology Market, Global, Branded versus Generic Drugs (%), 2010 18

Figure 6: Endocrinology Market, Revenue Forecasts by Country, $m, 2004-2018 19

Figure 7: Endocrinology Market, The US, Revenue, $bn, 2004-2018 21

Figure 8: Endocrinology Market, The US, Annual Cost of Therapy, $, 2004-2018 22

Figure 9: Endocrinology Market, The US, Treatment Usage Patterns, Millions, 2004-2018 23

Figure 10: Endocrinology Market, Top Five Countries of Europe, Revenue Forecasts, $m, 2004-2018 25

Figure 11: Endocrinology Market, Top Five Countries of Europe, Revenue Forecasts by Country, $m, 2004-2018 26

Figure 12: Endocrinology Market, Top Five Countries of Europe, Annual Cost of Therapy, $, 2004-2018 27

Figure 13: Endocrinology Market, Top Five Countries of Europe, Treatment Usage Patterns, Millions, 2004-2018 28

Figure 14: Endocrinology Market, Japan, Revenue Forecasts, $m, 2004-2018 30

Figure 15: Endocrinology Market, Japan, Annual Cost of Therapy, $, 2004-2018 31

Figure 16: Endocrinology Market, Japan, Treatment Usage Patterns, Millions, 2004-2018 32

Figure 17: Growth Hormone Deficiency Therapeutics Market, Global, Treatment Flow Algorithm, 2011 35

Figure 18: Growth Hormone Deficiency Therapeutics Market, Global, Revenue Forecasts, $bn, 2004-2018 36

Figure 19: Growth Hormone Deficiency Therapeutics Market, Global, Revenue by Country, $m, 2004-2018 37

Figure 20: Growth Hormone Deficiency Therapeutics Market, Global, Annual Cost of Therapy, $, 2004-2018 39

Figure 21: Growth Hormone Deficiency Therapeutics Market, Global, Treatment Usage Patterns, Thousands, 2004-2018 40

Figure 22: Acromegaly Therapeutics Market, Global, Treatment Flow Algorithm, 2011 43

Figure 23: Acromegaly Therapeutics Market, Global, Revenue Forecasts, $m, 2004-2018 44

Figure 24: Acromegaly Therapeutics Market, Global, Revenue by Country, $m, 2004-2018 45

Figure 25: Acromegaly Therapeutics Market, Global, Annual Cost of Therapy, $, 2004-2018 47

Figure 26: Acromegaly Therapeutics Market, Global, Treatment Usage Patterns, 2004-2018 48

Figure 27: Male Hypogonadism Therapeutics Market, Global, Treatment Flow Algorithm, 2011 50

Figure 28: Male Hypogonadism Therapeutics Market, Global, Revenue Forecasts, $m, 2004-2018 51

Figure 29: Male Hypogonadism Therapeutics Market, Global, Revenue by Country, $m, 2004-2018 52

Figure 30: Male Hypogonadism Therapeutics Market, Global, Annual Cost of Therapy, $, 2004-2018 54

Figure 31: Male Hypogonadism Therapeutics Market, Global, Treatment Usage Patterns, Thousands, 2004-2018 55

Figure 32: Hypothyroidism Therapeutics Market, Global, Treatment Flow Algorithm, 2011 58

Figure 33: Hypothyroidism Therapeutics Market, Global, Revenue Forecasts, $m, 2004-2018 59

Figure 34: Hypothyroidism Therapeutics Market, Global, Revenue by Country, $m, 2004-2018 61

Figure 35: Hypothyroidism Therapeutics Market, Global, Annual Cost of Therapy, $, 2004-2018 63

Figure 36: Hypothyroidism Therapeutics Market, Global, Treatment Usage Patterns, Millions, 2004-2018 64

Figure 37: Endocrinology Market, Global, Market Share by Company, %, 2010 66

Figure 38: Endocrinology Market, Global, SWOT - Pfizer, 2011 68

Figure 39: Endocrinology Market, Global, SWOT - Novartis, 2011 69

Figure 40: Endocrinology Market, Global, SWOT - Abbott, 2011 70

Figure 41: Endocrinology Market, Global, SWOT - Novo Nordisk, 2011 71

Figure 42: Endocrinology Market, Global, SWOT - Eli Lilly, 2011 72

Figure 43: Endocrinology Market, Global, R&D Pipeline by Indication, %, 2011 73

Figure 44: Endocrinology Market, Global, R&D Pipeline by Phase, %, 2011 74

Figure 45: Endocrinology Market, Global, M&A Deals by Type, %, 2005-2011 79

Figure 46: Endocrinology Market, Global, Major Licensing Agreements By Indication (%), 2005-2011 80

Figure 47: Endocrinology Market, Global, Major Licensing Agreements By Phase (%), 2005-2011 81

Figure 48: Endocrinology Market, Global, Major Licensing Agreements By Geography, %, 2005-2011 82

Figure 49: GBI Research Market Forecasting Model 90

 

Companies mentioned

 

Pfizer

Novartis

Abbott

Novo Nordisk

Eli Lilly

 

 

 

To order this report:

Therapy Industry: Endocrinology Market to 2018 - Advanced Injection Devices for Growth Hormone and Somatostatin will Improve Ease of Use for Patients

More Market Research Report

Check our Industry Analysis and Insights

 

Contact Nicolas: nbo@reportlinker.com

US: (805)-652-2626

Intl: +1 805-652-2626

 


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved


Related medicine technology :

1. New Clinical Endocrinology Guidelines Support Lp-PLA2 Measurement For Risk Assessment of Coronary Artery Disease
2. Pivotal Data Demonstrating Efficacy of Plenadren® (Hydrocortisone, Modified Release Tablet) in Adrenal Insufficiency Published in the Journal of Clinical Endocrinology and Metabolism
3. Elsevier Appoints Top Diabetes and Endocrinology Researchers as Editors
4. Reportlinker Adds Metabolic Endocrinology Hypocalcemia
5. CSC Announces Billing Contract with Denver Endocrinology Diabetes and Metabolism
6. Study Published in Endocrinology Reports Potential of Modigene Technology to Extend Duration of Protein Drugs
7. ResearchMoz: The World Anesthesia Drug Market (General, Local, Adjunctive) - Market Research Report
8. OTC Pharmaceuticals: Global Industry Almanac, MarketLine
9. Ophthalmic Drugs: World Market Prospects 2012-2022
10. Althea Technologies Appoints Dr. Kristin DeFife, Director, Biologics Manufacturing And Jack Wright, VP, Sales and Marketing
11. International Drug & Explosives Detection Company IDenta Corp. Releases Information to OTC markets.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 24, 2016 Dehaier Medical Systems Ltd. (NASDAQ: ... develops, markets and sells medical devices and wearable sleep ... a strategic cooperation agreement with Hongyuan Supply Chain Management ... on June 20, 2016, to develop Dehaier,s new Internet ... agreement, Dehaier will leverage Hongyuan Supply Chain,s sales platform ...
(Date:6/24/2016)... -- Research and Markets has announced the addition ... report to their offering. ... The World Market for Companion Diagnostics covers the world ... in the report includes the following: , ... by Region (N. America, EU, ROW), 2015-2020 , World ...
(Date:6/24/2016)... --  Pulmatrix, Inc ., (NASDAQ: PULM ), ... today that it was added to the Russell Microcap ... set of U.S. and global equity indexes on June ... for Pulmatrix," said Chief Executive Officer Robert Clarke ... in developing drugs for crucial unmet medical needs, and ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... 2016 , ... Today, InhaleLabs.com (Inhale) offilially launched its site, which ... users with high quality water pipes within an ideal price range. The site is ... founded by two brothers, Nick and Mike Hunter, who use medical cannabis to heal ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Dr. Seema Daulat, ... Evans Dermatology in the South Lamar location as of July 13, 2016. , Dr. ... School. As a medical student, she regularly volunteered at the Agape Clinic serving Dallas’ ...
(Date:6/23/2016)... , ... June 23, 2016 , ... An article ... expose a possible link between head and neck cancer in individuals with unhealthy oral ... study were evaluated based on whether they had gum disease, brushed their teeth on ...
(Date:6/23/2016)... ... June 23, 2016 , ... The Mechille Wilson Agency, a Texas-based insurance company ... the surrounding region, is initiating a charity drive to assist a student to be ... a scholarship fund that will be presented to the chosen student to help with ...
(Date:6/23/2016)... ... ... Virginia Beach resident Sean Kelly suffered from depression after a long military career ... set out to accomplish a personal mission: a solo 50-mile paddle. Kelly decided to ... the story of another special operations veteran, Josh Collins, whom Kelly had served with ...
Breaking Medicine News(10 mins):